GY II Represses Proliferation and Metastasis and Promotes Apoptosis in Laryngeal Squamous Cell Carcinoma

Yunfei Bai,Ru Wang,Xiaobo Cui,Lin Feng,Qian Shi,Hongzhi Ma,Meng Lian,Xixi Shen,Yifan Yang,Chen Tan,Jugao Fang
DOI: https://doi.org/10.15761/icst.1000298
2018-01-01
Integrative Cancer Science and Therapeutics
Abstract:Traditional Chinese Medicine (TCM) has been considered to provide certain advantages in the treatment of cancer. Guben Yiliu II (GY II) has been widely used for clinical treatment of cancer in China. The current study investigated the effects of GY II on proliferation, apoptosis, invasion, and metastasis of laryngeal squamous cell carcinoma via MTT assays, Transwell assays, and flow cytometry, respectively, in Hep-2 and cells from clinical samples. Results of MTT assays revealed that GY II inhibited the growth of cells via arresting the cell cycle at G0/G1 phase. The addition of GY II significantly suppressed cell migration and invasion. Additionally, GY II treatment significantly promoted apoptosis of tumor cells. Present findings have significant implications regarding the understanding of mechanisms and targets of GY II in terms of tumors.
What problem does this paper attempt to address?